Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Evaluation of efficacy in terms of progression-free survival at 9 months of the combination of intensified methotrexate, vinblastine, doxorubicin and cisplatin (I-MVAC) with or without panitumumab as first-line treatment of advanced urothelial carcinoma in patients without H-Ras nor K-Ras mutations.
Critère d'inclusion
- Advanced urothelial carcinoma in patients without H-Ras nor K-Ras mutations